Paraguay’s Treatment Posted byjascallyJuly 18, 2021Posted inProxalutamide Kintor Pharmaceutical Receives Emergency Use Authorization for Proxalutamide for the Treatment of COVID-19 in Paraguay | BioSpace Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Like Loading... Related